Zevra Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 4.46 M | $41.53 M | -1.12% | 8.06% |
| WOODLINE PARTNERS LP | 05/15/2026 | 3.45 M | $32.16 M | 0.00% | 6.24% |
| FMR LLC | 05/15/2026 | 3.21 M | $29.93 M | 34.19% | 5.81% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.52 M | $23.50 M | 42.33% | 4.56% |
| 05/15/2026 | 2.47 M | $23.01 M | 100.00% | 4.46% | |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 2.00 M | $18.67 M | 81.87% | 3.62% |
| STATE STREET CORP | 05/15/2026 | 1.56 M | $14.55 M | 5.30% | 2.82% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.37 M | $12.79 M | 2.25% | 2.48% |
| AIGH CAPITAL MANAGEMENT LLC | 04/30/2026 | 1.20 M | $11.18 M | 100.00% | 2.17% |
| MORGAN STANLEY | 05/15/2026 | 1.19 M | $11.11 M | 2.97% | 2.16% |
| LEGAL & GENERAL GROUP PLC | 05/08/2026 | 1.16 M | $10.84 M | 5.93% | 2.10% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 1.16 M | $10.78 M | 100.00% | 2.09% |
| ROYCE & ASSOCIATES LP | 05/12/2026 | 988.67 K | $9.21 M | 14.19% | 1.79% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 975.00 K | $9.09 M | 7.73% | 1.76% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 846.46 K | $7.89 M | -2.00% | 1.53% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 842.32 K | $7.85 M | 136.45% | 1.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 05/15/2026 | 775.00 K | $7.22 M | 32.46% | 1.40% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 743.12 K | $6.93 M | 26.23% | 1.34% |
| RETIREMENT PLANNING CO OF NEW ENGLAND, INC. | 05/08/2026 | 651.15 K | $6.07 M | -1.78% | 1.18% |
| CITADEL ADVISORS LLC | 05/15/2026 | 626.70 K | $5.84 M | -25.65% | 1.13% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 590.27 K | $5.50 M | -47.96% | 1.07% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 554.80 K | $5.17 M | 259.17% | 1.00% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 05/14/2026 | 506.03 K | $4.44 M | 0.00% | 0.91% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 480.00 K | $4.47 M | -15.65% | 0.87% |
| 05/08/2026 | 466.30 K | $4.35 M | 100.00% | 0.84% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 452.80 K | $4.22 M | 129.61% | 0.82% |
| TUDOR INVESTMENT CORP ET AL | 05/15/2026 | 443.11 K | $4.13 M | -35.98% | 0.80% |
| MARSHALL WACE, LLP | 05/15/2026 | 439.95 K | $4.10 M | -34.31% | 0.80% |
| NORTHERN TRUST CORP | 05/14/2026 | 436.95 K | $4.07 M | 4.50% | 0.79% |
| UBS GROUP AG | 05/05/2026 | 422.05 K | $3.93 M | 47.83% | 0.76% |
| STRATOS WEALTH PARTNERS, LTD. | 04/28/2026 | 408.00 K | $3.80 M | -0.24% | 0.74% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 395.88 K | $3.69 M | 100.00% | 0.72% |
| JPMORGAN CHASE & CO | 05/13/2026 | 378.93 K | $3.33 M | -8.08% | 0.69% |
| MYSTIC ASSET MANAGEMENT, INC. | 05/08/2026 | 361.28 K | $3.37 M | 4.26% | 0.65% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 05/05/2026 | 350.50 K | $3.27 M | 100.00% | 0.63% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 282.42 K | $2.64 M | 343.47% | 0.51% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 255.24 K | $2.38 M | -52.74% | 0.46% |
| CITADEL ADVISORS LLC | 05/15/2026 | 243.40 K | $2.27 M | 54.83% | 0.44% |
| JANNEY MONTGOMERY SCOTT LLC | 04/22/2026 | 236.83 K | $2.21 M | 16.73% | 0.43% |
| JANE STREET GROUP, LLC | 05/12/2026 | 221.06 K | $2.06 M | -60.80% | 0.40% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 200.00 K | $1.86 M | -27.27% | 0.36% |
| NUVEEN, LLC | 04/30/2026 | 192.59 K | $1.79 M | 34.55% | 0.35% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 186.58 K | $1.74 M | -36.34% | 0.34% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 182.86 K | $1.70 M | -42.33% | 0.33% |
| JANE STREET GROUP, LLC | 05/12/2026 | 178.70 K | $1.67 M | 274.63% | 0.32% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 05/13/2026 | 177.16 K | $1.65 M | 26.92% | 0.32% |
| KOVACK ADVISORS, INC. | 05/13/2026 | 175.23 K | $1.65 M | -0.06% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 172.43 K | $1.61 M | -0.99% | 0.31% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 161.98 K | $1.51 M | -10.32% | 0.29% |
| PHOCAS FINANCIAL CORP. | 05/01/2026 | 159.42 K | $1.49 M | 100.00% | 0.29% |
Zevra Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 180 institutional investors and hedge funds held shares of Zevra Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 4.46 M
Woodline Partners LP: 3.45 M
FMR LLC: 3.21 M
Nantahala Capital Management, LLC: 2.52 M
STATE STREET CORP: 1.56 M
GEODE CAPITAL MANAGEMENT, LLC: 1.37 M
74.70% of Zevra Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 44.58 M shares in the last 24 months. This purchase volume represents approximately $406.60 M in transactions.